These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36647730)

  • 1. Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching.
    Yu Y; Feng Y; Zhou Z; Li K; Hu X; Liao L; Xing H; Shao Y
    Emerg Microbes Infect; 2023 Dec; 12(1):e2169196. PubMed ID: 36647730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.
    Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA
    J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
    Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in HIV-1 gp120 V3 region are necessary but not sufficient for coreceptor switching in CRF07_BC in China.
    Zhang L; Ma L; Wang Z; Wang Y; Zhang J; Wang H; Shao Y
    PLoS One; 2014; 9(3):e93426. PubMed ID: 24676404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selected amino acid mutations in HIV-1 B subtype gp41 are associated with specific gp120v₃ signatures in the regulation of co-receptor usage.
    Dimonte S; Mercurio F; Svicher V; D'Arrigo R; Perno CF; Ceccherini-Silberstein F
    Retrovirology; 2011 May; 8():33. PubMed ID: 21569409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
    Pastore C; Nedellec R; Ramos A; Pontow S; Ratner L; Mosier DE
    J Virol; 2006 Jan; 80(2):750-8. PubMed ID: 16378977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
    Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
    Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2.
    Xiang SH; Pacheco B; Bowder D; Yuan W; Sodroski J
    Virology; 2013 Mar; 438(1):5-13. PubMed ID: 23369572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
    Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charged amino acid patterns of coreceptor use in the major subtypes of human immunodeficiency virus type 1.
    Pramanik L; Fried U; Clevestig P; Ehrnst A
    J Gen Virol; 2011 Aug; 92(Pt 8):1917-1922. PubMed ID: 21525208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
    Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
    Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.
    Pollakis G; Kang S; Kliphuis A; Chalaby MI; Goudsmit J; Paxton WA
    J Biol Chem; 2001 Apr; 276(16):13433-41. PubMed ID: 11278567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.
    Antell GC; Dampier W; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; Schwartz G; Hershberg U; Krebs FC; Wigdahl B
    Retrovirology; 2016 May; 13(1):32. PubMed ID: 27143130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of mutations outside the V3 region on coreceptor tropism phenotypically assessed in patients infected with HIV-1 subtype B.
    Monno L; Saracino A; Scudeller L; Punzi G; Brindicci G; Altamura M; Lagioia A; Ladisa N; Angarano G
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5078-84. PubMed ID: 21876051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
    Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
    J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position 22 of the V3 loop is associated with HIV infectivity.
    Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
    Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A virus-envelope paired competitive assay to study entry efficiency of human immunodeficiency virus type 1 in vitro.
    Schwalbe B; Hauser H; Schreiber M
    J Virol Methods; 2014 Sep; 205():91-8. PubMed ID: 24859049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.